Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis / 결핵
Tuberculosis and Respiratory Diseases
;
: 102-117, 2019.
Artículo
en Inglés
| WPRIM
| ID: wpr-742452
ABSTRACT
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome. The members of the Korean Academy of Tuberculosis and Respiratory Diseases as well as the participating members of the Korea Interstitial Lung Disease Study Group drafted this clinical practice guideline for IPF management. This guideline includes a wide range of topics, including the epidemiology, pathogenesis, risk factors, clinical features, diagnosis, treatment, prognosis, and acute exacerbation of IPF in Korea. Additionally, we suggested the PICO for the use of pirfenidone and nintendanib and for lung transplantation for the treatment of patients with IPF through a systemic literature review using experts' help in conducting a meta-analysis. We recommend this guideline to physicians, other health care professionals, and government personnel in Korea, to facilitate the treatment of patients with IPF.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pronóstico
/
Tuberculosis
/
Epidemiología
/
Factores de Riesgo
/
Trasplante de Pulmón
/
Enfermedades Pulmonares Intersticiales
/
Manejo de la Enfermedad
/
Atención a la Salud
/
Diagnóstico
/
Disnea
Tipo de estudio:
Estudio diagnóstico
/
Estudio de etiología
/
Guía de Práctica Clínica
/
Estudio pronóstico
/
Factores de riesgo
/
Revisiones Sistemáticas Evaluadas
Límite:
Humanos
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Tuberculosis and Respiratory Diseases
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS